Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study

Background: For patients with hepatocellular carcinoma (HCC), the definition of refractoriness to transarterial chemoembolization (TACE), which might make them a candidate for systemic therapy, is still controversial. We aimed to derive and validate a tumor marker-based algorithm to define the refra...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jun Sik, Sinn, Dong Hyun, Lee, Jeong-Hoon, Kim, Hwi Young, Lee, Cheol-Hyung, Kim, Sun Woong, Lee, Hyo Young, Nam, Joon Yeul, Chang, Young, Lee, Yun Bin, Cho, Eun Ju, Yu, Su Jong, Kim, Hyo-Cheol, Chung, Jin Wook, Kim, Yoon Jun, Yoon, Jung-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896068/
https://www.ncbi.nlm.nih.gov/pubmed/31689972
http://dx.doi.org/10.3390/cancers11111721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896068/
https://www.ncbi.nlm.nih.gov/pubmed/31689972
http://dx.doi.org/10.3390/cancers11111721

Ejemplares similares